Cory Jubinville, PhD
Stock Analyst at LifeSci Capital
(4.54)
# 969
Out of 4,442 analysts
162
Total ratings
48.4%
Success rate
19.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cory Jubinville, PhD
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Maintained: Buy | $6 | $3.24 | +85.19% | 6 | Jun 23, 2026 | |
| TNYA Tenaya Therapeutics | Maintained: Buy | $4 | $0.726 | +450.96% | 31 | Jun 3, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Hold | n/a | $0.3223 | - | 14 | Jan 12, 2026 | |
| CRNX Crinetics Pharmaceuticals | Maintained: Buy | $93 → $99 | $35.91 | +175.69% | 30 | Jan 5, 2026 | |
| SION Sionna Therapeutics | Initiated Coverage: Buy | $60 | $39.87 | +50.49% | 1 | Dec 23, 2025 | |
| IKT Inhibikase Therapeutics | Initiated Coverage: Buy | $5 | $1.87 | +167.38% | 1 | Dec 1, 2025 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $88 | $30.60 | +187.58% | 5 | Nov 18, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintained: Buy | $9 | $3.47 | +159.37% | 17 | Nov 7, 2025 | |
| LRMR Larimar Therapeutics | Maintained: Buy | $22 | $3.68 | +497.83% | 21 | Nov 5, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintained: Buy | $85 → $84 | $66.17 | +26.95% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $67 | $74.04 | -9.51% | 22 | Nov 3, 2025 |
Prime Medicine
Jun 23, 2026
Maintained: Buy
Price Target: $6
Current: $3.24
Upside: +85.19%
Tenaya Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: $4
Current: $0.726
Upside: +450.96%
Mereo BioPharma Group
Jan 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.3223
Upside: -
Crinetics Pharmaceuticals
Jan 5, 2026
Maintained: Buy
Price Target: $93 → $99
Current: $35.91
Upside: +175.69%
Sionna Therapeutics
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $60
Current: $39.87
Upside: +50.49%
Inhibikase Therapeutics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.87
Upside: +167.38%
Tectonic Therapeutic
Nov 18, 2025
Maintained: Buy
Price Target: $88
Current: $30.60
Upside: +187.58%
Rocket Pharmaceuticals
Nov 7, 2025
Maintained: Buy
Price Target: $9
Current: $3.47
Upside: +159.37%
Larimar Therapeutics
Nov 5, 2025
Maintained: Buy
Price Target: $22
Current: $3.68
Upside: +497.83%
Tarsus Pharmaceuticals
Nov 5, 2025
Maintained: Buy
Price Target: $85 → $84
Current: $66.17
Upside: +26.95%
Nov 3, 2025
Maintained: Buy
Price Target: $54 → $67
Current: $74.04
Upside: -9.51%